Prenetics Global Limited - Ordinary Shares - Class A

NASDAQ:PRE 4:00:00 PM EDT

4.97

+0.18 (+3.76%)

5:55:22 PM EDT: $5.49 +0.52 (+10.46%)

Market Cap (Intraday)	60.29M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$38.78 Million
Adjusted EPS	-$0.30

See more estimates

10-Day MA	$4.07
50-Day MA	$4.42
200-Day MA	$6.17

See more pivots

Prenetics Global Limited - Ordinary Shares - Class A Stock, NASDAQ:PRE

K11 Atelier King's Road, 728 King's Road, Unit 703-706, Hong Kong, George Town KY1-1106

Hong Kong

Phone: +852.2210.9588

Number of Employees:

http://www.prenetics.com

Description

Prenetics Global Ltd. is a genomics-driven health sciences company, which engages in the prevention, early detection, and treatment of diseases. It operates through the Prevention and Diagnostic segments. The Prevention segment is involved in the design and sale of genetics testing and stool-based DNA tests for early colorectal cancer screening. The Diagnostic segment consists of COVID-19 testing services and products, and precision oncology services. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and is headquartered in Hong Kong.